五元均一店 FIVE
$240.30 −$0.96 (-0.40%)
休市 · Nov 7, 10:00 pm ET · 最新盘后价 $240.30 0.00%
开盘$240.74
昨收$241.26
当日区间$235.50 – $241.89
成交量473.8K
市值$13.23B
市盈率（TTM）21.6
股息率–
FIVE 相关新闻
匹配 Five Below 或代码 FIVE 的头条新闻，按最新排序。
- Telsey Advisory Maintains Five Below(FIVE.US) With Buy Rating, Maintains Target Price $305
- Mizuho Securities Maintains Five Below(FIVE.US) With Buy Rating, Raises Target Price to $295 正面
- A Quick Look at Today's Ratings for Five Below(FIVE.US), With a Forecast Between $295 to $420
- Aim for the water network to cover 82% of the national land area by the end of the 15th Five-Year Plan.
- Meihu Co., Ltd.: Announcement Regarding Penalties or Regulatory Measures Imposed by Securities Regulatory Authorities and Stock Exchanges on the Company Over the Past Five Years
- Netstars: Connecting five major domestic card payment brands to Land. By integrating with a payment platform used by over 5 million companies worldwide, StarPay is expanding its service offerings.
- Yida Co., Ltd.: Announcement Regarding the Absence of Any Penalties or Regulatory Measures Imposed by Securities Regulatory Authorities or Stock Exchanges Over the Past Five Years
- A Quick Look at Today's Ratings for Five Below(FIVE.US), With a Forecast Between $260 to $340
- U.S. job openings fell to a five-month low in August, while layoffs remained subdued. 负面
- Evercore Maintains Five Below(FIVE.US) With Hold Rating, Raises Target Price to $250 正面
- Zhongda Lide: Announcement by Ningbo Zhongda Lide Intelligent Transmission Co., Ltd. Regarding Regulatory Measures or Penalties Imposed by Securities Regulatory Authorities and Stock Exchanges in the Past Five Years
- Bernstein Upgrades Five Below(FIVE.US) to Buy Rating, Maintains Target Price $272 正面
- Major Broker Ratings | Citi: The "15th Five-Year" Plan for the pharmaceutical industry is favorable to innovative drugs and medical devices; Hengrui Pharma and Innovent Bio are our top picks, among others.
- Telsey Advisory Maintains Five Below(FIVE.US) With Buy Rating, Maintains Target Price $280
- Apple posts a five-week winning streak: Evercore raised its price target to $380, saying the iPhone upgrade cycle is better than expected. 正面
暂无评论——快来第一个聊聊 FIVE。
登录后参与讨论。